BioCentury
ARTICLE | Financial News

Intec raises $30.2M in U.S. listing

August 4, 2015 11:36 PM UTC

Intec Pharma Ltd. (Tel Aviv:INTP; NASDAQ:NTEC) held at $6 in its first day of trading on NASDAQ after it raised $30.2 million through the sale of 5 million shares at $6 in a U.S. listing underwritten by Maxim Group and Roth Capital Partners.

The price values the company at $63.8 million. Intec filed in June to raise up to $46 million. ...